Courses

This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC). The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. This CE program will include updates from the European Society for Medical Oncology 2018 Congress as well as a review of current relevant ...
View Course

This continuing education activity will focus on recent clinical trial data as well as therapeutic advances in the increasing role of biosimilars in oncology. The three expert faculty will review the fundamentals of biosimilars in oncology, including bioequivalence, totality of evidence, and interchangeability. A review of current clinical trial data of biosimilars for the treatment of various oncologic therapeutic areas ...
View Course

This continuing education activity will focus on recent clinical trial data and scientific advances in the treatment and management of patients with metastatic colorectal cancer as presented at the 2018 Gastrointestinal Cancers Symposium held in San Francisco, California. Three expert faculty will review the science of colorectal cancer, including patient screening guidelines and molecular characterization. Recent clinical trial data of ...
View Course

This CE program will analyze optimal therapeutics for the treatment and management of prostate cancer patients, incorporating data presented at the American Society of Clinical Oncology 2018 Genitourinary (GU) Cancers Symposium in San Francisco, California. The three expert faculty, led by Dr. Elisabeth Heath, will review the framework for clinical decision making in prostate cancer. Recent clinical trial data for ...
View Course

This CME/CE program will delve into the role of oncolytic viral therapy in the treatment and management of the metastatic melanoma patients, highlighting data presented at the Maui and Hawaii Dermatology 2018 annual meetings. The three expert faculty will review the immunotherapy for melanoma, followed by a discussion of recent safety and efficacy trial data for this emerging therapeutic option ...
View Course

This CME/CNE program will highlight recent advances in the treatment and management of breast cancer, as presented at the 40^th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Three expert faculty will review the pathophysiology of breast cancer and the rationale for therapeutic choices. An evaluation of recent clinical trial data of current and emerging therapies will be ...
View Course

This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59^th Annual Meeting & Exposition in Atlanta, Georgia. The expert faculty panel will provide learners with a scientific update regarding kidney toxicity, fractures, and other skeletal related events as they relate to MM patient care. Recent ...
View Course

This CE program will highlight recent scientific advances in the treatment and management of patients with polycythemia vera (PV) presented at the American Society of Hematology 59^th Annual Meeting & Exposition in Atlanta, Georgia. The three expert faculty will review the science and diagnostic criteria of PV, focusing on the treatment of the resistant/intolerant patient population. Recent clinical trial data, ...
View Course